Hackensack University Medical Center # 408 — Hackensack, New Jersey

Hackensack University Medical Center # 408 is a clinical research site located in Hackensack, New Jersey, United States 07601.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Hackensack University Medical Center # 408 has participated in 1 clinical trials.

Therapeutic areas: Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, Acute Myelogenous Leukemia.

Sponsors: Astellas Pharma Inc.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Hackensack University Medical Center # 408?

Hackensack University Medical Center # 408 has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Hackensack University Medical Center # 408 conducted?

Hackensack University Medical Center # 408 has 1 clinical trials on record. Their work covers Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, Acute Myelogenous Leukemia.

Is Hackensack University Medical Center # 408 accredited by Crixeo Health?

Hackensack University Medical Center # 408 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Hackensack University Medical Center # 408?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.